1.64 is roughly $300 Million. No way. I am not one who believes the acquisition price will be $20 Billion, but I think we should get at least $1 Billion based on what we know about Peregrine. Current market cap values Bavituximab at about $100 Million alone. Eventually the market will come around once management decides to start promoting the company, until then we remain astounded about the MC.